Although these previous studies revealed AnxA2 as an important player for breast cancer progression, the expression of AnxA2 protein in tumor tissues of different subtypes of breast cancer patients and its role as a secretory biomarker for breast cancer prognosis and diagnosis has not been studied. This evidence concerns the gene ANXA2 and neoplasm.